Qatar Investment Authority

FAASOS is a food service brand that operates primarily as a cloud kitchen, focusing on on-demand food delivery. It specializes in delivering meals through its in-house brands while also utilizing a dark-kitchen model to efficiently prepare and distribute food. By leveraging advanced technology and culinary expertise, FAASOS ensures high food quality and a diverse menu for consumers. The brand aims to enhance the dining experience by offering a variety of options from nearby restaurants, making it convenient for customers to enjoy their favorite meals at home. Through its innovative approach, FAASOS positions itself as a key player in the evolving food delivery market.

Lomond Therapeutics is a pharmaceutical firm that discovers and develops small molecule inhibitors that target escape variants in hematologic malignancies.

Supira Medical, Inc. is a medical device company that specializes in developing a percutaneous ventricular assist device (pVAD) aimed at high-risk patients undergoing interventional procedures. This innovative device provides temporary mechanical support to assist the heart's native pumping action, making it a critical solution for patients facing severe coronary artery disease or cardiogenic shock during coronary interventions. The company's technology is designed to facilitate recovery in patients who require urgent mechanical support, thereby enhancing their ability to undergo necessary medical procedures. Founded in 2012 and based in Campbell, California, Supira Medical was previously known as Lumenblation Medical, Inc. before rebranding in March 2016.

Arbor Biotechnologies, Inc., founded in 2016 and based in Cambridge, Massachusetts, operates within the biotechnology sector, focusing on bio-discovery and human diagnostic development. The company utilizes a range of advanced technologies, including artificial intelligence, genome sequencing, gene synthesis, and high-throughput screening, to facilitate the discovery of proteins aimed at enhancing human health and sustainability. Arbor's proprietary genomic tools leverage AI and machine learning to analyze genomic sequence data, thereby improving the efficiency of developing curative treatments for genetic diseases. These innovations enable drug developers to replace entire genes and precisely correct mutations, ultimately addressing previously untreatable genetic conditions.

Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain. The company aims to target pain at its source to provide effective, rapid-acting pain relief without the risk of addiction. Their lead program targets Nav1.8, a validated human pain target, leveraging internal ion channel expertise.

Voldex is a prominent company in the user-generated content (UGC) gaming sector, specializing in creating engaging games for platforms such as Roblox, Fortnite Creative, and Minecraft. Established in 2015, the company has built a strong portfolio that attracts nearly 25 million monthly active users, positioning it among the top grossing developers on Roblox. Voldex operates as a video gaming studio that transforms unique game concepts into reality, enhancing the gaming experience for users. With a dedicated team of 60 full-time employees, Voldex continues to innovate within the gaming landscape.

Instabase, Inc. is a technology company that develops a platform aimed at automating document processing workflows and analyzing unstructured data. Founded in 2015 and based in San Francisco, California, the company provides a range of services, including optical character recognition, data classification and extraction, and natural language processing. Its platform is designed to help organizations in various sectors, such as insurance, finance, and healthcare, streamline operations and improve decision-making. By enabling businesses to embed artificial intelligence into their systems and processes, Instabase facilitates the development of applications that address significant operational challenges, particularly in the realm of intelligent document processing.

Databricks Inc. offers a unified data analytics cloud platform that simplifies data engineering and supports collaborative data science. Its core product, Databricks, enables organizations to process and analyze large datasets efficiently, leveraging tools like Apache Spark. The platform is designed for real-time experimentation and robust deployment of production applications, catering to developers and data scientists. Additionally, Databricks provides Databricks Delta, a data management system that combines the scalability of a data warehouse with low-latency streaming capabilities. The company also offers MLflow for managing the machine learning lifecycle and Delta Lake for handling batch and streaming data. Databricks serves a diverse range of industries, including healthcare, finance, manufacturing, and telecommunications. Founded in 2013 and headquartered in San Francisco, with additional offices in London, Amsterdam, and Bengaluru, Databricks has established strategic partnerships to enhance its offerings and foster innovation in data and AI technologies.

AUDI AG is a prominent manufacturer of luxury vehicles known for its sporty performance, high build quality, and innovative design, encapsulated in its motto "Vorsprung durch Technik." As a subsidiary of the Audi Group, the company offers a diverse range of premium cars and is actively engaged in transforming mobility for the future. Through a strategic approach, AUDI AG is adapting to new trends and technologies to maintain its influential position in the automotive industry.

XAI develops artificial intelligence technologies for data analysis and decision-making. It uses machine learning algorithms to increase accuracy. XAI operates in finance, healthcare, and logistics industries.

Cresta is a company that specializes in enhancing customer service through artificial intelligence. It provides a customer experience platform that assists sales and service agents by managing inquiries and facilitating effective communication with customers. The platform is designed to surface relevant information at critical moments, thereby improving the quality of customer interactions. By augmenting the capabilities of sales teams, Cresta enables businesses to significantly increase productivity and conversion rates, effectively doubling the efficiency of their customer service operations.

Beta Technologies specializes in the design and development of electric aircraft, including advanced flight control and electric propulsion systems, with a strong emphasis on clean aviation technology. The company aims to establish a new paradigm for transporting goods and people through its self-sufficient electric vertical takeoff and landing (eVTOL) aircraft ecosystem. This ecosystem is designed to meet human mobility needs while adhering to environmental principles. Additionally, Beta Technologies is working on a comprehensive electric transportation system that features net-zero, all-electric aircraft and a multimodal charging infrastructure to support various electric vehicles. The company also offers training programs for pilots and maintenance personnel, catering to clients in the cargo, passenger, and emergency response sectors, and enabling them to implement more efficient, cleaner, and faster transportation solutions.

ONE Championship is Asia's largest sports media property with a global broadcast to over 1 billion potential viewers across 128 countries. Headquartered in Singapore, the world’s most exciting martial arts organization is home to some of the greatest martial artists in the world, hosting Asia's greatest sports entertainment events in the largest stadiums of the most iconic cities across the region.

TechMet Limited is a private industrial company based in Dublin, Ireland, founded in 2017. It focuses on building, controlling, and monitoring projects throughout the technology metal supply chain, specifically targeting essential metals such as nickel, cobalt, lithium, rare earth metals, vanadium, tungsten, and tin. These metals are crucial for advanced technologies, particularly in electric vehicles, renewable energy systems, and energy storage devices. TechMet aims to secure a stable and sustainable supply of these critical resources, which often face supply chain challenges. The company's investments span various stages of the supply chain, including mining, processing, refining, and recycling, with interests in production and development assets located in Africa, North America, and South America.

Outpace Bio is a biotechnology company that creates smart cell therapies aimed at improving efficacy and safety. It offers a platform that combines custom-designed biological functions with cellular control modalities that program the right response at the right time and place. It creates a mechanism-driven solution tailor-made to improve efficacy and safety. The company collaborates with Lyell Immunopharma to develop and commercialize a potential immune cell therapy for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders, enabling healthcare providers to cure a wide range of diseases as per patient's need.

Bright Peak Therapeutics is a biotechnology company focused on developing immunotherapies for cancer and autoimmune diseases. The company specializes in cytokine therapeutics that enable tissue and cell-specific targeting of cytokine payloads. This approach aims to enhance the efficacy of treatments, ultimately improving patient outcomes and quality of life. By leveraging innovative immuno-cytokines, Bright Peak seeks to provide more effective therapeutic options for complex medical conditions.

ITM Isotopen Technologien München AG is a privately held biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radionuclides for use in cancer treatment. Since its foundation in 2004, ITM and its subsidiaries have established GMP manufacturing and a robust global supply network of a novel, first-in-class medical radionuclides and -generator platform for a new generation of targeted cancer diagnostics and therapies. ITM’s isotope business is profitable and growing. In July 2016 the European Commission has granted Marketing Authorization for EndolucinBeta® of ITM´s subsidiary ITG Isotope Technologies Garching GmbH. EndolucinBeta® respectively no-carrier-added (n.c.a.) Lutetium (177Lu) chloride is a radiopharmaceutical precursor and is used in Targeted Radionuclide Therapy. The drug approval is an important milestone for ITM as a specialized radiopharmaceutical company. Furthermore, ITM is developing a proprietary portfolio and growing pipeline of targeted treatments in various stages of clinical development, which address a range of cancers such as neuroendocrine cancers or bone metastases. ITM’s main objectives, together with its scientific, medical and industrial collaboration partners worldwide, are to significantly improve outcomes and quality of life for cancer patients while at the same time reducing side effects and improving health economics through a new generation of Targeted Radionuclide Therapies in Precision Oncology.

The Iambic AI-driven platform was created to address the most challenging design problems in drug discovery, leveraging technology innovations such as Enchant, a multi-modal transformer model that predicts clinical outcomes from the earliest stages of discovery, and NeuralPLexer, the best-in-class predictor of protein and protein-ligand structures. The integration of physics principles into the platform’s AI architectures improves data efficiency and allows molecular models to venture widely across the space of possible chemical structures. The platform enables identification of novel chemical modalities for engaging difficult-to-address biological targets, discovery of defined product profiles that optimize therapeutic window, and multi-parameter optimization for highly differentiated development candidates. Through close integration of AI-generated molecular designs with automated experimental execution, Iambic completes design-make-test cycles on a weekly cadence.

Canary Wharf Group has already achieved one of the greatest ever feats of civic engineering, turning a once derelict Docklands into 97 acres of London’s, and the world’s, most sought after office and retail space. The Group’s workforce comprises more than 950 people who are dedicated to one of the three sub companies. Canary Wharf Limited, Canary Wharf Contractors Limited and Canary Wharf Management Limited.

Precede Biosciences is breaking down the barriers to precision medicine by redefining what can be gleaned from a simple blood draw. Precede aims to increase drug development success rates and to contribute to a future in which every patient can receive a speedy, minimally invasive diagnosis and therapy tailored to the biology of their condition.

BridgeBio is a biotechnology company that focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D. BridgeBio creates a bridge from advancements in genetic science to patients with unmet needs via the entrepreneurial engine required to make life-changing medicines as rapidly as possible. BridgeBio's mission is to discover, create, test, and deliver transformative medicines to treat patients with genetic diseases.

Databricks Inc. offers a unified data analytics cloud platform that simplifies data engineering and supports collaborative data science. Its core product, Databricks, enables organizations to process and analyze large datasets efficiently, leveraging tools like Apache Spark. The platform is designed for real-time experimentation and robust deployment of production applications, catering to developers and data scientists. Additionally, Databricks provides Databricks Delta, a data management system that combines the scalability of a data warehouse with low-latency streaming capabilities. The company also offers MLflow for managing the machine learning lifecycle and Delta Lake for handling batch and streaming data. Databricks serves a diverse range of industries, including healthcare, finance, manufacturing, and telecommunications. Founded in 2013 and headquartered in San Francisco, with additional offices in London, Amsterdam, and Bengaluru, Databricks has established strategic partnerships to enhance its offerings and foster innovation in data and AI technologies.

Ascend Elements specializes in the production of advanced battery materials by reclaiming valuable elements from spent lithium-ion batteries. The company employs hydroprocess recycling and direct recycling methods, which deconstruct old cathode materials at the atomic level to generate new cathode materials. This innovative approach not only enhances the efficiency of recycling processes but also enables clients to maximize their returns on assets, ultimately supporting the production of economically viable and low-cost battery materials.

Star Therapeutics is a biotechnology company focused on developing innovative therapies for a wide range of rare diseases. The company aims to identify diseases that share common biological characteristics and create novel therapeutics that can effectively treat multiple conditions with a single treatment. This approach not only addresses the needs of patients suffering from rare diseases but also presents a unique opportunity for pharmaceutical companies to broaden their therapeutic offerings within a streamlined pipeline. By concentrating on life-changing therapies, Star Therapeutics aspires to make a significant impact on the lives of millions of patients.

Carsome is an online platform that simplifies the process of selling used cars for individuals and businesses. Founded in 2015 and headquartered in Malaysia, the company has expanded its operations to Indonesia, Thailand, and Singapore. Carsome's services include vehicle inspection, valuation, and a bidding system that connects sellers directly with dealers, allowing for a quick and efficient sale, often within a day. The platform also manages logistics and ownership transfers, ensuring a seamless experience for customers. In addition to selling cars, Carsome offers a curated selection of pre-owned vehicles for buyers. Overall, Carsome aims to provide a hassle-free and transparent car selling and buying experience.

ITM Isotopen Technologien München AG is a privately held biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radionuclides for use in cancer treatment. Since its foundation in 2004, ITM and its subsidiaries have established GMP manufacturing and a robust global supply network of a novel, first-in-class medical radionuclides and -generator platform for a new generation of targeted cancer diagnostics and therapies. ITM’s isotope business is profitable and growing. In July 2016 the European Commission has granted Marketing Authorization for EndolucinBeta® of ITM´s subsidiary ITG Isotope Technologies Garching GmbH. EndolucinBeta® respectively no-carrier-added (n.c.a.) Lutetium (177Lu) chloride is a radiopharmaceutical precursor and is used in Targeted Radionuclide Therapy. The drug approval is an important milestone for ITM as a specialized radiopharmaceutical company. Furthermore, ITM is developing a proprietary portfolio and growing pipeline of targeted treatments in various stages of clinical development, which address a range of cancers such as neuroendocrine cancers or bone metastases. ITM’s main objectives, together with its scientific, medical and industrial collaboration partners worldwide, are to significantly improve outcomes and quality of life for cancer patients while at the same time reducing side effects and improving health economics through a new generation of Targeted Radionuclide Therapies in Precision Oncology.

Insider is a growth management platform that assists digital marketers in enhancing their strategies from customer acquisition to retention and revenue generation. Founded in 2012 and headquartered in Singapore, Insider leverages real-time predictive segmentation driven by advanced artificial intelligence and machine learning. This technology enables marketers to create personalized customer journeys across various channels, including web, mobile apps, and advertising platforms. The platform is designed for ease of implementation and use, minimizing the need for complex integrations or IT dependencies. By unifying data and providing actionable insights, Insider helps clients optimize their marketing spending, improve product discovery, and enhance overall brand experiences. The company operates globally with offices in multiple countries, including the United Kingdom, Japan, the United Arab Emirates, and Australia, serving a diverse range of industries such as retail, finance, and travel.

Builder.ai is a technology company that provides an AI-powered platform for building and managing applications and websites. The platform simplifies the software development process, enabling enterprises, small businesses, and entrepreneurs to create, operate, and scale software projects without needing technical expertise or coding skills. The company's key offerings include an AI-driven tool called Builder, which oversees the entire development process, and CloudOps, an extension that integrates automation with financial control for cloud infrastructure management. Founded in January 2012 and headquartered in San Francisco, California, Builder.ai aims to make software development accessible to a broader audience.

OriCell Therapeutics develop drugs with good efficacy and affordable prices to satisfy the globally unmet clinical needs through innovations and strives to become the world-leading developer of novel drugs for tumor immunotherapy.

Ensoma is a biotechnology company focused on advancing genomic medicine through its innovative in vivo approach using Engenious vectors. These vectors are engineered to facilitate the delivery of gene modification technologies directly to blood and immune cells, including T cells, B cells, and myeloid cells, without the need for stem cell collection or harmful pre-treatment procedures like chemotherapy. This unique capability allows Ensoma to administer therapies through a single injection, making it possible to deliver effective treatments in outpatient settings and areas with limited access to advanced healthcare systems. By streamlining the process of gene therapy, Ensoma aims to enhance the accessibility and curative potential of genomic medicine for patients with various diseases.

Snyk Ltd. is a software as a service company that provides a platform for identifying, fixing, and monitoring vulnerabilities in applications. Founded in 2015 and headquartered in London, with additional offices in Tel Aviv, Boston, and Ontario, Snyk offers a range of solutions tailored for developers and security teams. Its key products include Snyk Code, a developer-first static application security testing tool, and container vulnerability management for securing Docker images. The platform also supports application security management, licensing compliance, and infrastructure as code security, ensuring that all components of modern applications are secure. Snyk’s Developer Security Platform integrates seamlessly into developers' workflows, promoting collaboration between development and security teams. The company serves over 1,200 customers globally, including notable organizations like Google and Salesforce, and has formed a strategic partnership with Rapid7. Snyk is recognized for its contributions to enhancing application security in an increasingly digital landscape.

THG Holdings plc is an online retailer and technology company based in Manchester, United Kingdom, specializing in fast-moving consumer goods, particularly in the health and beauty sectors. The company provides a comprehensive direct-to-consumer e-commerce solution for brand owners through Software as a Service licenses. THG is engaged in the manufacture and retail of nutrition, wellbeing, skincare, haircare, and cosmetics products, operating over 100 high-profit websites that cater to the global market. Additionally, THG offers a range of services including website development, online advertising, marketing, and procurement. The company also has ventures in luxury fashion, hairdressing salons, hotels, and health clubs. Founded in 2004, THG was formerly known as The Hut Group Limited before rebranding in 2020.

BYJU'S is a prominent global ed-tech company founded in India in 2011, dedicated to providing engaging and effective learning solutions to over 150 million students worldwide. Its mission focuses on making high-quality education accessible, with a diverse range of offerings that include BYJU's: The Learning App and other brands like Disney-BYJU's Early Learn and BYJU's FutureSchool. The company's platform utilizes original content, watch-and-learn videos, animations, and interactive simulations to create a personalized educational experience that adapts to each student's unique learning style and pace. With a team of over 12,000 teachers, BYJU'S supports pre-K–12 education and various competitive exams, employing innovative methods that enhance engagement. The company has established partnerships with major firms such as Disney and Google to expand its reach and impact. Headquartered in India, BYJU'S operates in more than 21 countries, offering learning programs in over eight languages, and has made significant acquisitions to broaden its educational footprint.

InnovaFeed is a biotech company specializing in the production of insect-based protein derived from the rearing of Hermetia illucens. The company focuses on providing sustainable and natural ingredients for animal feed, particularly in the aquaculture sector. By utilizing its unique technological expertise, InnovaFeed integrates insects into the agri-food system, enhancing nutrient recycling and contributing to a more sustainable food supply. Their products, which include quality insect oil rich in lauric acid, offer antimicrobial benefits and serve as an alternative to imported oils in poultry and swine feed. InnovaFeed addresses the growing global demand for protein while promoting environmentally friendly practices in food production.

JenaValve Technology, Inc. is a medical device company specializing in the development and manufacturing of transcatheter aortic valve replacement (TAVR) systems designed for patients with severe aortic stenosis and aortic regurgitation. The company's flagship product, the Trilogy Heart Valve System, features a porcine pericardial trileaflet valve mounted on a self-expanding nitinol frame, which allows for both transapical and transfemoral implantation. This innovative system is particularly aimed at high-risk patients and has received CE Mark approval, as well as Breakthrough Device Designation from the U.S. Food and Drug Administration to expedite its review process in the United States. JenaValve operates from its headquarters in Irvine, California, with additional facilities in Munich, Germany, and Leeds, United Kingdom. The company aims to transform the treatment landscape for heart valve diseases through its advanced technologies.

Celonis specializes in execution management, focusing on helping companies optimize their business processes through its advanced process mining technology. The company's core offering, the Celonis Execution Management System (EMS), provides a comprehensive suite of tools and applications that assist organizations in managing various aspects of execution, from analytics and strategy to planning, management, and automation. By leveraging its unique software solutions, Celonis enables businesses across industries such as production, human resources, and logistics to enhance productivity, improve process transparency, and increase operational efficiency. The emphasis on analyzing and optimizing online business processes positions Celonis as a key player in the field of management consultancy and automation.

Senda Biosciences, founded in 2017 in Cambridge, Massachusetts, focuses on developing therapeutic applications for innovative treatments of human diseases. The company investigates the molecular relationships among bacterial, botanical, and human cells, aiming to understand how these interactions influence health and disease. By leveraging insights from these interspecies connections, Senda Biosciences seeks to create new categories of medicines and delivery methods that can assist medical professionals in providing effective treatments.

Starling Bank Limited is a digital-only bank based in London, United Kingdom, founded in 2014. It offers a range of personal and business banking services, including personal, joint, and business accounts. The bank provides digital banking solutions that allow users to manage their finances through a mobile platform. Its services include real-time spending intelligence, financial and accounting tools, and same-day payment options, all designed to facilitate paperless and branchless transactions. By focusing on innovative technology, Starling Bank aims to enhance the banking experience for both individuals and businesses.

BioXcel Therapeutics, a clinical-stage biopharmaceutical company based in New Haven, Connecticut, specializes in drug development using artificial intelligence to advance therapies in neuroscience and immuno-oncology. The company has developed BXCL501, a sublingual film formulation of dexmedetomidine, which is approved for the acute treatment of agitation associated with schizophrenia and bipolar disorder. Additionally, BXCL701, an immuno-oncology agent, is being investigated for the treatment of prostate and pancreatic cancers as well as other solid tumors. BioXcel Therapeutics employs a unique approach that combines existing approved drugs with advanced machine learning algorithms to identify new therapeutic applications, aiming to improve the efficiency and effectiveness of drug development for conditions with significant unmet medical needs. The company was founded in 2017 and is a subsidiary of BioXcel Corporation.

BioXcel Therapeutics, a clinical-stage biopharmaceutical company based in New Haven, Connecticut, specializes in drug development using artificial intelligence to advance therapies in neuroscience and immuno-oncology. The company has developed BXCL501, a sublingual film formulation of dexmedetomidine, which is approved for the acute treatment of agitation associated with schizophrenia and bipolar disorder. Additionally, BXCL701, an immuno-oncology agent, is being investigated for the treatment of prostate and pancreatic cancers as well as other solid tumors. BioXcel Therapeutics employs a unique approach that combines existing approved drugs with advanced machine learning algorithms to identify new therapeutic applications, aiming to improve the efficiency and effectiveness of drug development for conditions with significant unmet medical needs. The company was founded in 2017 and is a subsidiary of BioXcel Corporation.

Insider is a growth management platform that assists digital marketers in enhancing their strategies from customer acquisition to retention and revenue generation. Founded in 2012 and headquartered in Singapore, Insider leverages real-time predictive segmentation driven by advanced artificial intelligence and machine learning. This technology enables marketers to create personalized customer journeys across various channels, including web, mobile apps, and advertising platforms. The platform is designed for ease of implementation and use, minimizing the need for complex integrations or IT dependencies. By unifying data and providing actionable insights, Insider helps clients optimize their marketing spending, improve product discovery, and enhance overall brand experiences. The company operates globally with offices in multiple countries, including the United Kingdom, Japan, the United Arab Emirates, and Australia, serving a diverse range of industries such as retail, finance, and travel.

Ventus Therapeutics is a biopharmaceutical company focused on discovering and developing novel small molecule medicines aimed at treating autoimmune diseases, inflammatory diseases, and cancer by targeting the innate immune system. The company employs a structural immunology platform that provides deep insights into the mechanisms and molecular structures involved in immune responses. This platform integrates proprietary protein engineering capabilities with advanced rational and structure-based drug design tools, allowing for precise targeting of the innate immune system. Ventus is actively building a pipeline of drug programs that address critical targets within this system, particularly proteins involved in inflammasome and nucleic acid-sensing signaling pathways, thereby enabling the treatment of both acute and chronic inflammatory and immune-related conditions.

Checkout.com is a payment processing company founded in 2012 that offers a robust online payments platform capable of handling transactions in over 150 currencies. The platform enables businesses to accept major international credit and debit cards, as well as various local and alternative payment methods. By integrating an end-to-end technology, Checkout.com eliminates intermediaries, allowing retailers to connect directly with customers' bank accounts. The company provides advanced fraud filters, customizable risk settings, and detailed data insights to enhance transaction security and optimize performance. With a global workforce of over 1,700 employees located in 19 offices, Checkout.com combines local expertise with a commitment to facilitating fast and reliable payments for businesses worldwide.

Carsome is an online platform that simplifies the process of selling used cars for individuals and businesses. Founded in 2015 and headquartered in Malaysia, the company has expanded its operations to Indonesia, Thailand, and Singapore. Carsome's services include vehicle inspection, valuation, and a bidding system that connects sellers directly with dealers, allowing for a quick and efficient sale, often within a day. The platform also manages logistics and ownership transfers, ensuring a seamless experience for customers. In addition to selling cars, Carsome offers a curated selection of pre-owned vehicles for buyers. Overall, Carsome aims to provide a hassle-free and transparent car selling and buying experience.

Space Perspective Inc. is a spaceflight company that offers tourists the opportunity to experience the edge of space through its innovative high-altitude balloon, Neptune. Established in 2019 and headquartered in Merritt Island, Florida, the company operates its first flight center on Florida's Space Coast, strategically located near NASA’s Kennedy Space Center. The flights launch from the historic runway used by the Space Shuttle. Passengers travel in a pressurized capsule that ascends via a stratospheric balloon, reaching an altitude of several kilometers. They remain at this height for approximately two hours before descending slowly and safely back to Earth, where they splash down in the ocean and are retrieved by a boat. Space Perspective aims to expand its operations to additional launch locations, including Cecil Spaceport in Florida, Hawaii, and Alaska, as part of its mission to facilitate human exploration of space for the benefit of all.

Infarm is a Berlin-based company founded in 2013 that designs and distributes efficient vertical farms for urban environments. By integrating IoT technologies and machine learning, Infarm provides a modular farming system that aims to create a resilient, transparent, and affordable alternative food system. The company’s compact growing kits enable cities to enhance their self-sufficiency in food production, improving the safety, quality, and environmental impact of the food supply. Through its innovative approach, Infarm seeks to transform how fresh produce is grown and consumed in urban areas.

ONE Championship is Asia's largest sports media property with a global broadcast to over 1 billion potential viewers across 128 countries. Headquartered in Singapore, the world’s most exciting martial arts organization is home to some of the greatest martial artists in the world, hosting Asia's greatest sports entertainment events in the largest stadiums of the most iconic cities across the region.

Travelling folks is a travel agency which is established in the year 2006 and is located in Jammu Kashmir India. In the l few years, we have been serving many clients We have been providing good quality service for all types of travelers. We are committed to providing our customers with the best possible services. Our team of experts will assist you in finding the perfect holiday package according to your budget and preferences.

FAASOS is a food service brand that operates primarily as a cloud kitchen, focusing on on-demand food delivery. It specializes in delivering meals through its in-house brands while also utilizing a dark-kitchen model to efficiently prepare and distribute food. By leveraging advanced technology and culinary expertise, FAASOS ensures high food quality and a diverse menu for consumers. The brand aims to enhance the dining experience by offering a variety of options from nearby restaurants, making it convenient for customers to enjoy their favorite meals at home. Through its innovative approach, FAASOS positions itself as a key player in the evolving food delivery market.

VerSe Innovation is a local language technology company that develops a discovery platform to consume and socialize with media. Its platform facilitates the curation of content and tracks user preferences through its vertical search and recommendation tools that provide users with personalized content and notifications.

Trendyol is a leading e-commerce platform based in Istanbul, Turkey, specializing in retailing a diverse range of products including fashion items for women, men, and children, as well as shoes, bags, accessories, cosmetics, and home decor. Established in 2010, Trendyol has grown to become the largest internet employer in Turkey, employing approximately 2,000 people. The company focuses on providing a seamless shopping experience powered by technology, allowing customers to purchase what they want at their convenience. In 2018, Trendyol formed a strategic partnership with Alibaba Group, marking the largest investment in Turkey's internet sector to date. With its extensive product offerings and commitment to customer satisfaction, Trendyol serves as a central hub for online shopping in Turkey and the MENA region.

PepGen is a clinical-stage biotechnology company based in Oxford, United Kingdom, focused on advancing nucleic acid therapeutics, particularly antisense oligonucleotides. Founded in 2018, the company aims to enhance the delivery and efficacy of these therapies through its proprietary Enhanced Delivery Oligonucleotide (EDO) platform. This innovative platform utilizes engineered peptides designed to improve tissue penetration, cellular uptake, and nuclear delivery of oligonucleotides. PepGen's technology has shown promise in preclinical studies, demonstrating the ability to transport therapeutics effectively into various target tissues, including smooth, skeletal, and cardiac muscle, as well as the central nervous system. The company's mission is to unlock the full potential of nucleic acid therapeutics to transform the treatment landscape for severe neuromuscular and neurological diseases.

T-knife is a developer of T cell receptors intended for T cell therapy of cancer.The company uses a humanized TCR mice platform to carry human TCRαβ gene loci and recombine a broad repertoire of human TCRs, enabling the efficient generation and virtual selection of cell receptors for any human tumor antigen.

QuantumScape develops solid-state lithium-metal batteries for electric vehicles and other energy storage applications. The company works to revolutionize the battery industry by producing a solid-state battery that will provide a substantially higher level of battery storage than other batteries currently on the market. It manufactures lithium batteries aimed to accelerate the commercialization of solid-state batteries. The company's innovative approach could significantly impact the future of electric transportation and renewable energy integration. Jagdeep Singh founded the company in San Jose, California in 2010.

Airtel Mobile Commerce BV is an Airtel Africa subsidiary that serves as the holding company for several of the company's mobile money operations in 14 African countries, including Kenya, Uganda, and Nigeria. The mobile money division runs one of the continent's largest financial services. It allows users to access mobile wallets, international money transfers, loans, and virtual credit cards.

Flipkart is an e-commerce marketplace based in Bengaluru, India, offering over 30 million products across more than 70 categories, including electronics, home appliances, and personal care items. Founded in 2007 by Binny and Sachin Bansal, the platform has grown to serve 75 million registered users and generates over 10 million daily visits. Flipkart efficiently handles approximately 8 million shipments per month, a figure that continues to rise. The company is also the parent of Flipkart Ventures, which invests in early-stage companies. In 2018, Flipkart was acquired by Walmart, further strengthening its position in the competitive e-commerce landscape. With a workforce of around 33,000 employees, Flipkart remains a significant player in the Indian online retail market.

Age of Learning, Inc., known for its flagship product ABCmouse.com Early Learning Academy, provides online educational resources for children ages 2 to 7, both in the United States and internationally. The platform offers a comprehensive curriculum that includes reading, math, science, health, social studies, art, and music, catering to preschool, pre-k, kindergarten, and 1st grade. ABCmouse.com for schools allows educators to assign personalized lessons aligned with standards, while also providing access for students at home. The company supports low-income families through its Head Start program and offers free access to its resources via public libraries. In addition to educational games and activities, the platform features interactive experiences, such as virtual farms and zoos, to enhance learning engagement. Age of Learning also develops programs like My Math Academy and My Reading Academy to improve math and literacy skills. With over 11 billion learning activities completed by more than 50 million children, the company stands as a leader in educational technology, committed to advancing equity and access in education. Established in 2007, Age of Learning is headquartered in Glendale, California.

Thumbtack, Inc. operates an online marketplace that connects homeowners with skilled professionals across various service sectors. The platform allows users to find and hire service providers for tasks such as moving, plumbing, electrical work, landscaping, and event management, among others. With a network of around 300,000 local service businesses, Thumbtack offers personalized guidance to homeowners, helping them navigate project timelines and make informed hiring decisions. Established in 2008 and headquartered in San Francisco, California, the company aims to simplify home management by enabling users to efficiently manage home-related tasks and improvements.

Bright Peak Therapeutics is a biotechnology company focused on developing immunotherapies for cancer and autoimmune diseases. The company specializes in cytokine therapeutics that enable tissue and cell-specific targeting of cytokine payloads. This approach aims to enhance the efficacy of treatments, ultimately improving patient outcomes and quality of life. By leveraging innovative immuno-cytokines, Bright Peak seeks to provide more effective therapeutic options for complex medical conditions.

OncoResponse Inc. is a Houston-based immuno-oncology company focused on discovering innovative cancer therapies through its proprietary human antibody platform. The company specializes in identifying fully human monoclonal antibodies that target high-value immuno-oncology targets, particularly those associated with immunosuppressive myeloid biology. By exploring the adaptive immune responses of cancer patients who have successfully undergone checkpoint inhibition, OncoResponse aims to develop therapeutic antibodies that can mitigate tumor microenvironment immunosuppression and enhance immune activation. This approach seeks to transform cold tumors into hot tumors, thereby improving treatment outcomes for cancer patients.

Entrada Therapeutics, Inc. is a biotechnology company focused on treating diseases through the intracellular delivery of biologics, such as proteins, peptides, and nucleic acids. Founded in 2016 and based in Boston, Massachusetts, the company aims to transform patient care by developing a new class of medicines that target intracellular mechanisms previously deemed inaccessible. Entrada's technology addresses challenges associated with delivering both large and small molecules, significantly enhancing the efficiency of therapeutic delivery into the cytosol. Its pipeline includes innovative therapies for neuromuscular diseases and other conditions, utilizing proprietary Endosomal Escape Vehicle (EEV) therapeutics to improve treatment outcomes across various organs and tissues.

Eat Just, Inc., founded in 2011 and based in San Francisco, California, focuses on creating plant-based food products aimed at improving the food system. The company offers a variety of items, including plant-based scrambled eggs, flavored mayonnaise, dressings, cookie doughs, and meat alternatives. Their flagship product, JUST Egg, has garnered significant recognition, being featured in lists such as Popular Science's "100 Greatest Innovations." Eat Just emphasizes innovation through a unique discovery platform for food ingredients, combining scientific research with culinary expertise from Michelin-starred chefs. The company has been acknowledged in various prestigious lists, including Fast Company’s "Most Innovative Companies" and Entrepreneur’s "100 Brilliant Companies."

Starling Bank Limited is a digital-only bank based in London, United Kingdom, founded in 2014. It offers a range of personal and business banking services, including personal, joint, and business accounts. The bank provides digital banking solutions that allow users to manage their finances through a mobile platform. Its services include real-time spending intelligence, financial and accounting tools, and same-day payment options, all designed to facilitate paperless and branchless transactions. By focusing on innovative technology, Starling Bank aims to enhance the banking experience for both individuals and businesses.

Century Therapeutics is a biotechnology company focused on developing advanced cell therapies using induced pluripotent stem cells (iPSCs) to treat various cancers, including hematologic and solid tumors. Founded in 2018 and based in Philadelphia, Pennsylvania, the company utilizes a unique allogeneic iPSC-derived cell therapy platform that integrates gene editing, protein engineering, and robust manufacturing capabilities. This innovative approach allows for the generation of modified immune effector cells, such as natural killer (NK) and T cells, designed to meet significant unmet medical needs. By employing techniques like CRISPR-mediated gene editing and proprietary chimeric antigen receptors, Century Therapeutics aims to enhance cell product performance and minimize rejection by the host immune system, thereby improving the efficacy of cancer treatments.

VerSe Innovation is a local language technology company that develops a discovery platform to consume and socialize with media. Its platform facilitates the curation of content and tracks user preferences through its vertical search and recommendation tools that provide users with personalized content and notifications.

Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Gene Writing holds the potential to become a new category in genetic medicine, building upon recent breakthroughs in gene therapy and gene editing while eliminating important limitations in their reach, utilization, and efficacy. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.

Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture, focusing on developing innovative antibodies to help more patients. HJB and MabSpace Biosciences merged and created Transcenta.

Inigo Ltd. is a specialty insurance and re-insurance company.

Praxis Precision Medicines is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders that involve neuronal imbalance. The company is advancing several lead product candidates, including PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator currently in Phase IIa trials for major depressive disorder and perimenopausal depression, and PRAX-944, a selective small molecule inhibitor of T-type calcium channels in Phase IIa trials for essential tremor. Additionally, Praxis is developing PRAX-562, a persistent sodium current blocker in Phase I trials for severe pediatric epilepsy and adult cephalgia, as well as PRAX-222, an antisense oligonucleotide targeting SCN2A epilepsy. The company also has a program for treating KCNT1 gain-of-function epilepsy. Established in 2015 and based in Cambridge, Massachusetts, Praxis collaborates with other organizations through various agreements to enhance its research and development efforts.

CureVac is a clinical-stage biopharmaceutical company based in Germany, focused on developing vaccines and therapies utilizing messenger RNA (mRNA). Founded in 2000, the company’s innovative approach involves using mRNA as a data carrier to instruct the body to produce proteins that can combat various diseases. CureVac's pipeline includes novel mRNA-based cancer immunotherapies, prophylactic vaccines for infectious diseases, and molecular therapies aimed at enhancing the body’s production of therapeutic proteins. Its most advanced candidate, CV9104, is currently in Phase IIb clinical trials for prostate cancer treatment. Additionally, CureVac has collaborated with GSK to create second-generation vaccines for seasonal influenza and COVID-19, as well as an avian influenza vaccine, while exploring other mRNA vaccine applications in oncology and various therapeutic areas.

Zuoyebang is an online education startup based in Beijing, China, founded in 2014 by Hou Jianbin. The company focuses on providing educational products and services for primary and high school students, utilizing artificial intelligence to enhance learning experiences. Its platform allows students to upload homework questions and seek answers, making it easier for them to tackle study-related challenges. In addition to homework assistance, Zuoyebang offers online courses, live lessons, and evaluations for students from kindergarten through 12th grade. The company has gained significant backing from prominent investors, including Baidu, Alibaba Group, Tiger Global Management, SoftBank Vision Fund, Sequoia Capital China, and FountainVest Partners.

Califia Farms' (Califia, pronounced like California), mission is to bring you delicious and mindful nourishment through California-grown fruits and nuts. Califia Farms is led by beverage visionary Greg Steltenpohl, bringing you beautifully bottled goodness from the San Joaquin Valley. The name comes from the Spanish legend of warrior queen Califia who ruled over the mythical island of California. Spanish conquistadors believed they had discovered Califia’s bountiful island when they first explored California.

BYJU'S is a prominent global ed-tech company founded in India in 2011, dedicated to providing engaging and effective learning solutions to over 150 million students worldwide. Its mission focuses on making high-quality education accessible, with a diverse range of offerings that include BYJU's: The Learning App and other brands like Disney-BYJU's Early Learn and BYJU's FutureSchool. The company's platform utilizes original content, watch-and-learn videos, animations, and interactive simulations to create a personalized educational experience that adapts to each student's unique learning style and pace. With a team of over 12,000 teachers, BYJU'S supports pre-K–12 education and various competitive exams, employing innovative methods that enhance engagement. The company has established partnerships with major firms such as Disney and Google to expand its reach and impact. Headquartered in India, BYJU'S operates in more than 21 countries, offering learning programs in over eight languages, and has made significant acquisitions to broaden its educational footprint.

SoFi is a financial services company founded in 2011 and headquartered in San Francisco, California. It offers a diverse range of products targeting early-stage professionals, including personal loans, MBA loans, and mortgage refinancing. In addition to lending, SoFi provides wealth management services that assist individuals in saving, spending, and investing their money. The company also offers financial solutions for retirement planning and student loan repayment management. Its comprehensive suite of services includes credit cards, checking and savings accounts, and small business financing, positioning SoFi as a versatile player in the financial sector.

Super is an insurtech company that offers a subscription service for home care and repair.

Airtel Africa Plc is a telecommunications company that offers a range of services, including mobile voice, data communication, and mobile money solutions across Nigeria, East Africa, and Francophone Africa. The company provides both prepaid and postpaid wireless voice services, international roaming, and fixed line telephone services. Its mobile money services encompass various financial solutions such as payment systems, microloans, savings, and international money transfers. Established in 2018 and headquartered in London, Airtel Africa aims to make mobile communications accessible and affordable, thereby contributing to economic and social development in the regions it serves. As of March 2020, the company catered to approximately 110.6 million customers, with significant revenue generated from its operations in Nigeria. Airtel Africa is a subsidiary of Airtel Africa Mauritius Limited and is committed to extending its network reach, particularly in rural areas, as part of its community development initiatives.

Lufax is a technology-driven personal financial services platform based in China and associated with Ping An Insurance. The company specializes in providing a range of financial services, including wealth management and retail credit facilitation. It offers investment services tailored for institutions and individual investors, focusing on financial asset transactions and transaction financing consulting. Additionally, Lufax provides services related to financial asset allocation and manages a platform for facilitating these transactions, thereby enhancing the efficiency of financial operations for its clients.